{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-031408","form_type":"8-K","ticker":null,"cik":"0001106838","company_name":"Sonnet BioTherapeutics Holdings, Inc.","filed_at":"2023-09-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.153219+00:00","generated_at":"2026-06-11T00:21:13.980404+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sonnet BioTherapeutics effects 1-for-22 reverse stock split effective August 31, 2023","bullets":["Every 22 pre-split shares converted to 1 post-split share; no fractional shares issued, cash paid in lieu.","Reverse split effective at 4:30 p.m. ET on August 31, 2023; trading on split-adjusted basis starts September 1.","CUSIP number changed to 83548R303; par value and authorized shares unchanged.","Stock options, warrants, and convertible securities adjusted proportionally."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-031408","json":"https://secwatch.observer/filing/0001493152-23-031408.json","markdown":"https://secwatch.observer/filing/0001493152-23-031408.md","text":"https://secwatch.observer/filing/0001493152-23-031408.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106838/000149315223031408/0001493152-23-031408-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106838/000149315223031408/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T00:21:13.980404+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"656e220cfebca538263944a6053ed458c7b0a179","claim":"Sonnet BioTherapeutics Holdings, Inc.: Filed Certificate of Amendment to effect a 1-for-22 reverse stock split of common stock, effective at 4:30 pm ET on August 31, 2023 (effective 2023-08-31).","evidence_excerpt":"On August 31, 2023 (the “ Effective Date ”), Sonnet BioTherapeutics Holdings, Inc. (the “ Company ”) filed a Certificate of Amendment to the Company’s Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware (the “ Certificate of Amendment ”), which effected, at 4:30 p.m. Eastern Time on August 31, 2023, a one-for-twenty two reverse stock split (the “ Reverse Stock Split ”) of the Company’s issued and outstanding shares of common stock, par value $0.0001 per share (the “ Common Stock ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1106838/000149315223031408/0001493152-23-031408-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-08-31"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}